SE7612234L - Nya piperidinderivat. - Google Patents

Nya piperidinderivat.

Info

Publication number
SE7612234L
SE7612234L SE7612234A SE7612234A SE7612234L SE 7612234 L SE7612234 L SE 7612234L SE 7612234 A SE7612234 A SE 7612234A SE 7612234 A SE7612234 A SE 7612234A SE 7612234 L SE7612234 L SE 7612234L
Authority
SE
Sweden
Prior art keywords
piperide
individuals
new
propyl
phenoxymethyl
Prior art date
Application number
SE7612234A
Other languages
English (en)
Swedish (sv)
Inventor
W-G Friebe
M Thiel
K Stach
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of SE7612234L publication Critical patent/SE7612234L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE7612234A 1975-11-07 1976-11-03 Nya piperidinderivat. SE7612234L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752549999 DE2549999A1 (de) 1975-11-07 1975-11-07 Piperidin-derivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
SE7612234L true SE7612234L (sv) 1977-05-07

Family

ID=5961166

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7612234A SE7612234L (sv) 1975-11-07 1976-11-03 Nya piperidinderivat.

Country Status (20)

Country Link
US (1) US4243807A (cs)
JP (1) JPS6055509B2 (cs)
AT (1) AT352726B (cs)
BE (1) BE847973A (cs)
CA (1) CA1077942A (cs)
CH (3) CH624102A5 (cs)
DD (1) DD126942A5 (cs)
DE (1) DE2549999A1 (cs)
DK (1) DK494876A (cs)
FI (1) FI763148A7 (cs)
FR (1) FR2330678A1 (cs)
GB (1) GB1502050A (cs)
HU (1) HU171237B (cs)
IE (1) IE43866B1 (cs)
IT (1) IT1063618B (cs)
LU (1) LU76141A1 (cs)
NL (1) NL7612286A (cs)
SE (1) SE7612234L (cs)
SU (3) SU633473A3 (cs)
ZA (1) ZA766381B (cs)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA848275B (en) * 1983-12-28 1985-08-28 Degussa New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
US4556664A (en) * 1984-03-13 1985-12-03 Gunnar A. K. Aberg Method and composition for the treatment of cardiac arrhythmias
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
US5231184A (en) * 1987-11-23 1993-07-27 Janssen Pharmaceutica N.V. Pridazinamine derivatives
US4822778A (en) * 1988-01-19 1989-04-18 Gunnar Aberg Membrane stabilizing phenoxy-piperidine compounds and pharmaceutical compositions employing such compounds
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
US5264420A (en) * 1990-09-27 1993-11-23 Merck & Co., Inc. Fibrinogen receptor antagonists
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
WO1992019595A1 (en) * 1991-05-07 1992-11-12 Merck & Co., Inc. Fibrinogen receptor antagonists
US5321034A (en) * 1991-05-07 1994-06-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5416099A (en) * 1991-10-29 1995-05-16 Merck & Co., Inc. Fibrinogen receptor antagonists
US5272158A (en) * 1991-10-29 1993-12-21 Merck & Co., Inc. Fibrinogen receptor antagonists
US5389631A (en) * 1991-10-29 1995-02-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5358956A (en) * 1992-10-14 1994-10-25 Merck & Co., Inc. Fibrinogen receptor antagonists
US5559127A (en) * 1992-10-14 1996-09-24 Merck & Co., Inc. Fibrinogen receptor antagonists
CA2150550A1 (en) * 1992-12-01 1994-06-09 Melissa S. Egbertson Fibrinogen receptor antagonists
US5441952A (en) * 1993-04-05 1995-08-15 Merck & Co., Inc. Fibrinogen receptor antagonists
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US5397791A (en) * 1993-08-09 1995-03-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5821241A (en) * 1994-02-22 1998-10-13 Merck & Co., Inc. Fibrinogen receptor antagonists
US5719144A (en) * 1995-02-22 1998-02-17 Merck & Co., Inc. Fibrinogen receptor antagonists
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
DE69615063T2 (de) * 1995-09-28 2002-04-25 Kaken Pharmaceutical Co., Ltd. Verfahren zur herstellung von 4-methylen piperidinen
US5789421A (en) * 1995-10-26 1998-08-04 Merck & Co., Inc. Fibrinogen receptor antagonist
US5780480A (en) * 1996-02-28 1998-07-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5889023A (en) * 1996-05-10 1999-03-30 Merck & Co., Inc. Fibrinogen receptor antagonist
US5981584A (en) * 1997-02-06 1999-11-09 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
WO2010011811A2 (en) 2008-07-24 2010-01-28 Theravance, Inc. 3-(phenoxyphenylmethyl)pyrrolidine compounds
EP2358674B1 (en) 2008-11-14 2013-01-02 Theravance, Inc. Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
JP2012524098A (ja) * 2009-04-15 2012-10-11 セラヴァンス, インコーポレーテッド 3−(フェノキシピロリジン−3−イル−メチル)ヘテロアリール、3−(フェニルピロリジン−3−イルメトキシ)ヘテロアリールおよび3−(ヘテロアリールピロリジン−3−イルメトキシ)ヘテロアリール化合物
WO2011008666A2 (en) * 2009-07-13 2011-01-20 Theravance, Inc. 3-phenoxymethylpyrrolidine compounds
WO2011011231A1 (en) 2009-07-21 2011-01-27 Theravance, Inc. 3-phenoxymethylpyrrolidine compounds
WO2011085291A1 (en) 2010-01-11 2011-07-14 Theravance, Inc. 1 - (2 - phenoxymethylphenyl) piperazine compounds as serotonin and norepinephrine reuptake inhibitors
US8530663B2 (en) * 2010-03-22 2013-09-10 Theravance, Inc. 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds
EP2627630B1 (en) 2010-10-11 2014-12-31 Theravance Biopharma R&D IP, LLC Serotonin reuptake inhibitors
US8501964B2 (en) 2010-12-03 2013-08-06 Theravance, Inc. Serotonin reuptake inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268951A (en) * 1969-06-12 1972-03-29 Pfizer Ltd Phenoxy-amines
DE2245061A1 (de) * 1972-09-14 1974-03-28 Boehringer Mannheim Gmbh Derivate des adenins
DE2401254A1 (de) * 1974-01-11 1975-11-27 Boehringer Mannheim Gmbh Neue derivate von n hoch 6-substituierten adeninen
DE2550000A1 (de) * 1975-11-07 1977-05-12 Boehringer Mannheim Gmbh Neue purin-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE2549999A1 (de) 1977-05-12
IE43866B1 (en) 1981-06-17
NL7612286A (nl) 1977-05-10
DK494876A (da) 1977-05-08
IT1063618B (it) 1985-02-11
SU662009A3 (ru) 1979-05-05
ZA766381B (en) 1977-10-26
SU867298A3 (ru) 1981-09-23
CH627166A5 (cs) 1981-12-31
AT352726B (de) 1979-10-10
FR2330678A1 (fr) 1977-06-03
DE2549999C2 (cs) 1989-01-26
JPS6055509B2 (ja) 1985-12-05
CA1077942A (en) 1980-05-20
CH624102A5 (cs) 1981-07-15
FI763148A7 (cs) 1977-05-08
FR2330678B1 (cs) 1980-11-07
LU76141A1 (cs) 1977-05-18
GB1502050A (en) 1978-02-22
DD126942A5 (cs) 1977-08-24
SU633473A3 (ru) 1978-11-15
HU171237B (hu) 1977-12-28
CH625788A5 (cs) 1981-10-15
ATA823776A (de) 1979-03-15
IE43866L (en) 1977-05-07
US4243807A (en) 1981-01-06
JPS5259163A (en) 1977-05-16
BE847973A (fr) 1977-05-04

Similar Documents

Publication Publication Date Title
SE7612234L (sv) Nya piperidinderivat.
ES8501754A1 (es) "un metodo de preparacion de nuevas sulfonamidas sustituidas" nota: se solicita como divisional de la patente de invencion n 516.504.
ES475677A1 (es) Procedimiento para la preparacion de nuevos 4-hidroxi-2h-1,2-benzotiazin-3-carboxamido-1,1-dioxidos.
BG29132A3 (en) Method of obtaining of cyclohexan derivatives
SE7706520L (sv) Guanidinderivat
KR830005148A (ko) 항 알러지성 이미도디설파마이드의 제조방법
FI861506A0 (fi) Foerfarande foer framstaellning av 1,2-ditiolan-3-pentansyra (tioktsyra).
FR2297615A1 (fr) Nouvelles perhalogenoalcoylamidines substituees comme stimulants cardiaques
DE3688950D1 (de) Substituierte Chinolinderivate.
ES447011A1 (es) Procedimiento para preparar 1,1,1,-triaril-alquilaminas.
BG34036A3 (bg) Метод за получаване на пропаргил -2- фениламино- имидазолини-(2) и техните присъединителни с киселина соли
DK121383A (da) Fremgangsmaade til fremstilling af 8-substituerede pyrrolizidinderivater
DK691287A (da) 5-floururacilderivater
ATE799T1 (de) Verfahren zur herstellung von isatosaeureanhydriden.
BG32116A3 (bg) Метод за получаване на 4''-амино-олеандомицинови производни
SE7902302L (sv) Nya n-fenylalaninderivat, deras framstellning och deras anvendning som lekemedel
BG28414A4 (bg) Метод за получаване на 1-хидрокси-тетрахидробензо(с)хинолинони
ES447751A1 (es) Procedimiento para preparar derivados de imidazolilquinazo- lina.
SE7606063L (sv) Forfarande for framstellning av tienopyridininderivat
ATE2521T1 (de) Verfahren zur herstellung von 2,3-dioxo-1,4benzoxazinderivaten.
FR2364214A2 (fr) Benzimidazo-(1,2-a)-quinoleines et leur preparation
ES8601141A1 (es) Un procedimiento para la produccion de derivados de isoquinolina sustituidos
FR2362191A1 (fr) Colorants naphtolactames
FR2362118A1 (fr) Nouvelles metaphenylenediamines et compositions tinctoriales les contenant
ES8801542A1 (es) Procedimiento para preparar compuestos arilsulfonicos.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7612234-0

Format of ref document f/p: F